Novartis Ag (NVS) Other financing activities (2009 - 2026)

Novartis Ag (NVS) has 16 years of Other financing activities data on file, last reported at $78.0 million in Q1 2026.

• Quarterly Other financing activities rose 239.13% year-over-year to $78.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$148.0 million (down 223.33% YoY) and the FY2025 annual result came in at -$203.0 million, down 336.05% from the prior year.
• Other financing activities advanced to $78.0 million in Q1 2026 per NVS's latest filing, from -$33.0 million in the prior quarter.
• The five-year high for Other financing activities was $150.0 million in Q4 2023, with the low at -$215.0 million in Q2 2025.
• Average Other financing activities over 5 years is $7.1 million, with a median of $23.0 million recorded in 2025.
• Year-over-year, Other financing activities tumbled 2783.33% in 2022 and soared 309.09% in 2025.
• Novartis Ag's Other financing activities stood at -$161.0 million in 2022, then jumped by 193.17% to $150.0 million in 2023, then sank by 81.33% to $28.0 million in 2024, then sank by 217.86% to -$33.0 million in 2025, then surged by 336.36% to $78.0 million in 2026.
• Business Quant data shows NVS's Other financing activities at $78.0 million in Q1 2026, -$33.0 million in Q4 2025, and $22.0 million in Q3 2025.